FDA Inspection 1201226 — BioLife Plasma Services L.P.
The FDA completed an inspection of BioLife Plasma Services L.P. on March 23, 2023 in Lewisville, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lewisville, TX (United States)